5/9/2025

The current volatile situation shouldn't preclude investors from buying stocks. Eli Lilly, Vertex, Meta Platforms, and Netflix all stand to enjoy solid growth. Market volatility and near-term uncertainty can be challenging to deal with these days -- or at any time.

Source: Yahoo

5/9/2025

The funding round was spearheaded by Earlybird Venture Capital and Sofinnova Partners.

Source: Yahoo

5/9/2025

Eli Lilly and Co: * ELI LILLY: EXPANDS PURDUE UNIVERSITY COLLABORATION WITH UPTO$250 MILLION INVESTMENT OVER NEXT 8 YEARS * ELI LILLY: EARLIER AGREEMENT WITH PURDUE...

Source: Finnhub

5/8/2025

It's always a good idea for retail investors to take a look at what professional investors are doing. With the second quarter of 2025 now over a month old, many investment funds will soon begin disclosing what stocks they held at the end of the first quarter, essentially providing investors a glimpse of what they bought and sold. It's a particularly interesting time to see how large institutional funds invested early in the year, given all of the volatility.

Source: Yahoo

5/8/2025

Eli Lilly (NYSE:LLY) recently announced leadership transitions, including new roles for Ilya Yuffa, Patrik Jonsson, and Kenneth Custer, marking a strategic shift aiming to expand its global market presence and enhance product reach. Over the past month, the company's stock appreciated by 7%, potentially reflecting investor confidence in its direction amid these changes. Strong quarterly financial results, with significant increases in sales and earnings, would have bolstered investor...

Source: Yahoo

5/8/2025

U.S. equities gained at midday when the U.S. and U.K. struck a new trade deal.

Source: Yahoo

5/8/2025

Many pharma bigwigs reported solid results, with some beating on earnings or revenues or both.

Source: Yahoo

5/8/2025

The Hartford Healthcare Fund (I Share) underperformed the S&P Composite 1500 Health Care Index during the quarter. Read more here.

Source: SeekingAlpha

5/8/2025

Eli Lilly (LLY) shares take a dip after Politico reports that President Trump will sign a new executive order around drug prices. Among chip stocks, Arm Holdings (ARM) slips lower after it was announced the Trump administration plans to repeal Biden-era curbs on AI chip exports. D-Wave Quantum (QBTS) stock surges by over 26% Thursday morning after the quantum computing company reported first quarter revenue soared by 509% year-over-year. Madison Mills and Truist Co-Chief Investment Officer and Chief Market Strategist Keith Lerner take a look at these top trending stocks. To watch more expert insights and analysis on the latest market action, check out more Catalysts here.

Source: Yahoo

5/8/2025

There is plenty of movement in equity markets during earnings season, but from a fundamental standpoint, investment theses seldom change. Eli Lilly continues to deliver results that would make any megacap pharmaceutical company incredibly proud. Its diabetes and obesity management medications did most of the heavy lifting, but older products, like cancer drug Verzenio, continue to perform well.

Source: Yahoo

5/8/2025

Even though Eli Lilly and Company ( NYSE:LLY ) posted strong earnings, investors appeared to be underwhelmed. Our...

Source: Yahoo

5/8/2025

Eli Lilly and Company (NYSE: LLY) today announced executive leadership transitions that will further enhance the company's ability to drive sustained, long-term growth and ensure that its medicines continue to reach millions of people worldwide.Lilly has experienced significant growth over the past several years, particularly in the U.S. and cardiometabolic health businesses. The company anticipates continued growth in these areas, along with further pipeline advancement. To help drive this next

Source: Yahoo

5/8/2025

Energy stocks in the lead on Thursday; drugmakers weigh on healthcare

Source: MarketWatch

5/8/2025

Hims & Hers achieved 136% YoY subscriber growth and unveiled ambitious 2030 goals. Discover how precision medicine drives their best quarter yet.

Source: SeekingAlpha

5/8/2025

BeiGene's innovative cancer treatments, Brukinsa and Tevimbra, are driving growth. Click for a look at ONC and its latest earnings results.

Source: SeekingAlpha

5/8/2025

Several factors have contributed to Lilly's share price decline, including earnings misses and increased competition. For a while, it seemed as if Eli Lilly (NYSE: LLY) could do no wrong. Along the way, Lilly became the largest healthcare company in the world based on market cap.

Source: Yahoo

5/8/2025

Eli Lilly and Co: * LILLY ANNOUNCES TRANSITIONS IN EXECUTIVE LEADERSHIP * ELI LILLY AND CO - ILYA YUFFA APPOINTED EVP AND PRESIDENT,LILLYUSA * ELI LILLY AND...

Source: Finnhub

5/8/2025

U.S. energy firms seek exemption from Trump to transport LNG on U.S.-built ships. China Airlines orders Boeing passenger and freighter models.

Source: SeekingAlpha

5/8/2025

Eli Lilly and Company announced executive leadership transitions that will further enhance the company's ability to drive sustained, long-term growth and ensure that its medicines continue to reach...

Source: Finnhub

5/7/2025

The Hartford Growth Opportunities Fund (I Share) underperformed the Russell 3000 Growth Index during the quarter. Read more here.

Source: SeekingAlpha